mesa laboratories, inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. mesa offers quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (bis) for medical device and pharmaceutical manufacturing sterilization monitoring. the datatrace data loggers and mesa bis are available to monitor and validate applications including steam and eo sterilization, autoclave validation, incubators, heat tunnels and more. mesa’s bi offering also includes bis for industrial use, hydrogen peroxide (h2o2), chlorine dioxide and more. the phoenix meter is a point-of-use dialysate qc meter used prior to each procedure. the 90xl meter is the industry standard for calibration of dialysis machines in the field. also available are industry leading nist-traceable calibration solutions. mesa also offers cap torque testers which are durable, reliable and computerized cap torque analyzers
Company profile
Ticker
MLAB
Exchange
Website
CEO
Gary Owens
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Danaher • Roper • Fortive • Ametek • Sensata Technologies Holding • Keysight • MKS Instruments • Cognex • Hurco Companies • Sypris Solutions ...
Former names
MESA LABORATORIES INC /CO
SEC CIK
Corporate docs
Subsidiaries
Agena Bioscience GmbH • Agena Bioscience, Inc. • Beijing GKE Science & Technology Co. Ltd. • GKE GmbH • Gyros DE GmbH • Gyros Finans AB • Gyros France Sarl • Gyros Patent AB • Gyros Protein Technology AB • Gyros Protein Technology Holding AB ...
IRS number
840872291
MLAB stock data
Latest filings (excl ownership)
DEF 14A
Definitive proxy
19 Jul 24
10-K
2024 FY
Annual report
28 Jun 24
NT 10-K
Notice of late annual filing
14 Jun 24
8-K
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
5 Jun 24
8-K
Mesa Labs Announces Amendment to Credit Facility and Repurchase of Senior Convertible Notes
8 Apr 24
8-K
Material Impairments
2 Apr 24
10-Q
2024 Q3
Quarterly report
5 Feb 24
8-K
Mesa Labs Announces Third Quarter Results
5 Feb 24
8-K
Mesa Laboratories Appoints Mark Capone to its Board of Directors
8 Jan 24
10-Q
2024 Q2
Quarterly report
6 Nov 23
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 28.21 mm | 28.21 mm | 28.21 mm | 28.21 mm | 28.21 mm | 28.21 mm |
Cash burn (monthly) | 3.33 k | 391.33 k | 91.78 mm | 22.97 mm | (no burn) | (no burn) |
Cash used (since last report) | 12.89 k | 1.51 mm | 354.83 mm | 88.81 mm | n/a | n/a |
Cash remaining | 28.20 mm | 26.70 mm | -326.62 mm | -60.60 mm | n/a | n/a |
Runway (months of cash) | 8460.3 | 68.2 | -3.6 | -2.6 | n/a | n/a |
Institutional ownership, Q1 2024
84.8% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 149 |
Opened positions | 135 |
Closed positions | 3 |
Increased positions | 7 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 497.54 bn |
Total shares | 4.59 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 830.99 k | $91.18 bn |
Conestoga Capital Advisors | 580.74 k | $63.73 bn |
Vanguard | 373.40 k | $40.97 bn |
Royce & Associates | 283.74 k | $31.13 bn |
MS Morgan Stanley | 251.42 k | $27.59 bn |
Ranger Investment Management | 229.15 k | $25.15 bn |
STT State Street | 201.73 k | $22.14 bn |
Eagle Asset Management | 145.76 k | $16.33 bn |
Boone Capital Management | 133.39 k | $14.64 bn |
Dimensional Fund Advisors | 123.17 k | $13.52 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Jun 24 | Sakys John | RSU Common Stock | Grant | Acquire A | No | No | 0 | 8,351 | 0.00 | 8,351 |
18 Jun 24 | Owens Gary M | RSU Common Stock | Grant | Acquire A | No | No | 0 | 25,607 | 0.00 | 25,607 |
18 Jun 24 | Archbold Brian David | RSU Common Stock | Grant | Acquire A | No | No | 0 | 7,516 | 0.00 | 7,516 |
14 Jun 24 | Sakys John | Common Stock | Payment of exercise | Dispose F | No | No | 91.6 | 572 | 52.40 k | 11,463 |
14 Jun 24 | Sakys John | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,304 | 0.00 | 12,035 |
14 Jun 24 | Sakys John | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 793 | 0.00 | 793 |
14 Jun 24 | Sakys John | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 511 | 0.00 | 0 |
14 Jun 24 | Archbold Brian David | Common Stock | Payment of exercise | Dispose F | No | No | 91.6 | 407 | 37.28 k | 1,040 |
14 Jun 24 | Archbold Brian David | Common Stock | Option exercise | Acquire M | No | No | 0 | 889 | 0.00 | 1,447 |
14 Jun 24 | Archbold Brian David | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 535 | 0.00 | 535 |
News
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
31 May 24
Mesa Laboratories Has Delayed The Release Of Its Fourth-quarter And Fiscal Year 2024 Financial Results, Originally Scheduled For Today
31 May 24
Mesa Laboratories Revises Earnings Announcement Date For Q4 Results To May 31, 2024
22 May 24
Press releases
MESA LABS DECLARES QUARTERLY DIVIDEND
8 Jul 24
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
5 Jun 24
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
31 May 24
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
22 May 24